Spacecraft captures solar eclipse from the moon
(dpa) - The lunar lander Blue Ghost experienced a total solar eclipse on the moon overnight, while a lunar eclipse was visible from some places on Earth.
Cameras on the Blue Ghost, built by Texas-based company Firefly Aerospace, recorded the Earth moving in front of the Sun across the lunar horizon and obscuring it, sending images back to Earth.
The two-metre-long spacecraft landed on the Moon in early March in the Mare Crisium, an area with a diameter of about 500 kilometres. It is currently examining the Moon with scientific instruments until Sunday.
The mission, called "Ghost Riders in the Sky,", is the first lunar mission for Firefly Aerospace, which had previously mainly developed launchers.
It's not the first time a device has captured a solar eclipse from another celestial body. In 1967, the "Surveyor 3" lunar mission took numerous pictures of the Earth as it moved in front of the Sun.
Two years later, the crew of Apollo 12 witnessed the same on their return from the Moon.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
LEADOPTIK Awarded Key Patents Across Three Continents
Strengthening Global IP Portfolio in Optical Imaging for Minimally Invasive Procedures SAN JOSE, Calif., June 6, 2025 /PRNewswire/ -- LEADOPTIK Inc., a Silicon Valley-based medical imaging company, today announced it has been awarded key patents for its proprietary optical probe across three continents: North America, Europe, and Asia. LEADOPTIK designs and manufactures optical probes for minimally invasive procedures, where two critical factors are essential: high-resolution imaging and a miniaturized form factor. High-resolution imaging enables real-time visualization of tissue microstructure, empowering clinicians with the insight needed to make more informed decisions—whether collecting biopsy samples, resecting tumor margins, or delivering therapies to targeted sites. Equally important is miniaturization. Space is at a premium during minimally invasive procedures, and LEADOPTIK's probe is designed with an exceptionally small footprint to navigate tight anatomical pathways without compromising performance. The company's innovation is powered by cutting-edge metasurface technology—flat optical components created through the fusion of nanofabrication and advanced optical design. Unlike traditional optics, metasurfaces enable ultra-thin, high-performance imaging systems that are ideal for integration into medical devices. These three newly granted patents underscore LEADOPTIK's leadership in medical imaging: U.S. Patent (#US11953698B1): Covers a novel device-level metasurface design that significantly extends imaging depth without sacrificing resolution. The patent was granted with 100% of its original claims—a testament to the novelty of LEADOPTIK's approach. European and Japanese Patents (PCT065237 & PCT029301): Protect both the current probe assembly method and alternative configurations that support expanded clinical applications. "Building robust and scalable medical devices is non-negotiable," said Reza Khorasaninejad, CEO and Co-founder of LEADOPTIK. "Our team has not only invented new optical designs but also developed novel methods of integrating them with semiconductor-grade manufacturing processes. These patents reflect our commitment to making next-generation imaging accessible, reliable, and globally protected." "Our intellectual property is the foundation of LEADOPTIK's competitive edge," said Dr. Jiang You, Co-Founder and VP of Medical Imaging. "These patents not only protect our unique optical architecture but also validate the deep technical innovation required to miniaturize high-resolution imaging. It's a major milestone that strengthens our ability to scale globally and expand into new clinical applications." About LEADOPTIK LEADOPTIK is a Silicon Valley-based company pioneering AI-enhanced real-time optical imaging at the point of biopsy. By integrating high-resolution microstructural visualization with emerging analytics, the LIA system bridges the gap between diagnosis, and therapy, supporting more precise and informed decision-making in interventional pulmonology and beyond. For more information, visit Media Contact:hello@ View original content: SOURCE LEADOPTIK Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Time Business News
4 hours ago
- Time Business News
SyntecBiofuel Plans to Open New Lab in Asia
Syntecbiofuel Strategic investment in microbial biofuel technology aims to accelerate Asia's clean energy transition and strengthen global supply chains SyntecBiofuel, a global leader in sustainable biofuel innovation, today announced the establishment of a new state-of-the-art research and development laboratory in Asia [location TBD, e.g., Singapore or South Korea]. This expansion underscores SyntecBiofuel's commitment to revolutionizing biofuel production through synthetic biology and scaling sustainable solutions tailored for the rapidly growing Asian market. The strategic move aligns with the region's accelerating focus on decarbonization and renewable energy adoption. The new lab will leverage Asia's abundant biomass feedstocks and foster collaboration with local academic institutions and industry partners to drive breakthroughs in microbial biofuel technology. 'Our mission is to bridge synthetic biology innovations with scalable biofuel solutions that meet global sustainability goals,' said [CEO Name], CEO of SyntecBiofuel. 'Asia's vibrant innovation ecosystem is pivotal in achieving net-zero targets worldwide, and this lab will serve as a catalyst for delivering affordable, carbon-neutral biofuels to one of the world's fastest-growing energy markets.' The lab's core research initiatives will focus on metabolic engineering, waste-to-fuel conversion technologies, and optimizing biofuel yield and efficiency. These efforts aim to reduce production costs and enable the deployment of sustainable aviation fuel (SAF) and bio-gasoline tailored for the Asian market. SyntecBiofuel plans to launch the facility by [expected opening date], with a hiring initiative to recruit leading scientists and engineers in bioenergy and synthetic biology. The company invites strategic partnerships with investors, policymakers, and green technology collaborators to accelerate the transition to a sustainable energy future. Founded in [Year], SyntecBiofuel is a UK-based clean technology company pioneering advanced biofuel solutions. Backed by multiple patents and successful commercial deployments, SyntecBiofuel delivers innovative, sustainable fuels that reduce carbon emissions and support the circular economy. Media Contact Get in Touch with SyntecBiofuel's Media Relations Team For all press inquiries, interview requests, or media partnerships, please contact: Follow Us Online Stay updated on the latest news, innovations, and events from SyntecBiofuel: TIME BUSINESS NEWS
Forbes
5 hours ago
- Forbes
The U.S. Government Is Stuck With SpaceX. But Trump Can Still Hurt It.
Donald Trump and Elon Musk arrive for a test launch of SpaceX's Starship rocket on November 19, 2024, in Brownsville, Texas. In the barrage of attacks that President Donald Trump and Elon Musk fired at each other Thursday, one stood out: Trump's threat to cancel federal contracts with companies owned by the world's richest man. The primary target: SpaceX, which has received at least $21 billion in government contracts, with about $13 billion still outstanding. Musk probably doesn't have much to fear. Legally, the Trump administration would likely enmire itself in lengthy legal disputes if it appeared to cancel contracts out of spite. Moreover, as the world's No. 1 launch provider and maker of low-Earth orbit satellites, SpaceX may have made itself indispensable. 'The [U.S. government] is simply too locked in to cut them off over a social media meltdown,' said Kimberly Siversen Burke, director of government affairs at the consultancy Quilty Space. Nonetheless, there are some types of contracts that could be vulnerable for cancellation, and ways the government could lessen its dependence on SpaceX going forward. The 134 rockets SpaceX launched last year accounted for 83% of all satellites put into orbit worldwide. With its reliable, partially reusable Falcon 9, the company has come to dominate U.S. national security launches. Its chief competitor, United Launch Alliance, a joint venture of Boeing and Lockheed Martin, has struggled to keep up, with multiyear delays in developing its new Vulcan rocket. The U.S. government may have more options to carry its military satellites to space going forward. Vulcan is now operational and Blue Origin, the space company founded by Musk's billionaire rival Jeff Bezos, pulled off a successful first launch of its New Glenn rocket in January. In the latest round of contracts awarded by Space Force, SpaceX won 28 launches from 2027 through 2032, a little more than half, with ULA getting 19 and Blue Origin seven. But ULA and Blue Origin have their hands full scaling up, said Todd Harrison, a defense and space analyst with the American Enterprise Institute. 'There's no replacing SpaceX. You just do not have the capacity in our other launch options.' SpaceX has also become a major supplier of national security satellites. The National Reconnaissance Office is depending on SpaceX to build out a multibillion-dollar network of hundreds of spy satellites in low-Earth orbit based on the company's Starshield platform. For delivering cargo and astronauts to the International Space Station, NASA has also had to rely on SpaceX, as Boeing has struggled to fix defects in its Starliner spacecraft. But there are some relatively small-dollar SpaceX contracts that could be vulnerable, said Burke. The government could lower its exposure to SpaceX by looking for early phase development programs that don't have a contractor locked in yet. For example, SpaceX has won roughly $140 million in contracts on an Air Force program to test whether commercial satellite services can be integrated into tactical military communications, Burke said. Another way Trump could hurt Musk, as well as Ukraine, would be to cancel or reduce a $537 million contract to provide Starlink satellite communications services to the Ukrainian military. But rather than targeting existing contracts, where the administration could make a greater impact is by steering new business to others and reorienting its plans. The Commerce Department could backtrack on a revamp announced in March to a $42 billion program to expand rural broadband access that was expected to make Starlink eligible to compete for grants. Till now the program has only included telecom companies laying fiber-optic cables. Trump could also pull back from the support he promised in his inaugural address for Musk's ultimate ambition: to reach Mars. 'Where Trump can single handedly harm SpaceX in a significant way is redirecting the mission goals for NASA,' Harrison said. Given how mercurial Musk has proven to be, perhaps diversifying away from SpaceX isn't a bad idea. Burke worries, however, that the bad blood will undo years of work to convince the Pentagon and other national security agencies that they can rely on any commercial companies. 'Elon's antics are threatening to rewind the tape,' she said. MORE FROM FORBES
